1. Home
  2. GKOS vs INTA Comparison

GKOS vs INTA Comparison

Compare GKOS & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • INTA
  • Stock Information
  • Founded
  • GKOS 1998
  • INTA 2000
  • Country
  • GKOS United States
  • INTA United States
  • Employees
  • GKOS N/A
  • INTA N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • INTA Computer Software: Prepackaged Software
  • Sector
  • GKOS Health Care
  • INTA Technology
  • Exchange
  • GKOS Nasdaq
  • INTA Nasdaq
  • Market Cap
  • GKOS 5.1B
  • INTA 5.6B
  • IPO Year
  • GKOS 2015
  • INTA 2021
  • Fundamental
  • Price
  • GKOS $89.91
  • INTA $53.90
  • Analyst Decision
  • GKOS Strong Buy
  • INTA Buy
  • Analyst Count
  • GKOS 13
  • INTA 11
  • Target Price
  • GKOS $135.15
  • INTA $66.33
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • INTA 530.3K
  • Earning Date
  • GKOS 04-30-2025
  • INTA 05-06-2025
  • Dividend Yield
  • GKOS N/A
  • INTA N/A
  • EPS Growth
  • GKOS N/A
  • INTA N/A
  • EPS
  • GKOS N/A
  • INTA N/A
  • Revenue
  • GKOS $404,523,000.00
  • INTA $483,457,000.00
  • Revenue This Year
  • GKOS $27.84
  • INTA $18.62
  • Revenue Next Year
  • GKOS $27.88
  • INTA $14.78
  • P/E Ratio
  • GKOS N/A
  • INTA N/A
  • Revenue Growth
  • GKOS 23.92
  • INTA 17.70
  • 52 Week Low
  • GKOS $77.10
  • INTA $30.42
  • 52 Week High
  • GKOS $163.71
  • INTA $77.74
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • INTA 46.43
  • Support Level
  • GKOS $84.26
  • INTA $51.44
  • Resistance Level
  • GKOS $92.27
  • INTA $57.93
  • Average True Range (ATR)
  • GKOS 3.94
  • INTA 2.29
  • MACD
  • GKOS 0.57
  • INTA 0.38
  • Stochastic Oscillator
  • GKOS 58.87
  • INTA 51.81

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About INTA Intapp Inc.

Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.

Share on Social Networks: